These two spinoffs still have appeal

Article Excerpt

Shares of these two firms have drifted lower since their spinoffs. We still like their long-term prospects, but Edgewell is the better choice for your new buying. HENRY SCHEIN INC. $74 is a hold. The company (Nasdaq symbol HSIC; Manufacturing & Industry sector; Shares outstanding: 136.1 million; Market cap: $10.1 billion; No dividend paid; Takeover Target Rating: Medium; www.henryschein.com) is the world’s largest provider of health-care products and services to doctors and dentists. It has over one million customers worldwide and operates in 33 countries, including the U.S., Canada, and the U.K. The company spun off its animal health business in February 2019. The spinoff then merged with privately held Vets First Choice to form Covetrus Inc. (Nasdaq symbol CVET on Nasdaq). Schein shareholders received 0.4 shares of Covetrus for every Schein share they held. In October 2022, Covetrus was taken private by investment companies Clayton, Dubilier & Rice and TPG Capital. In July 2023, Schein paid $326 million for S.I.N. Implant System, a leading dental implant…